At a record pace, pharmaceutical companies have developed vaccine candidates to prevent COVID-19 infection, with early results promising high efficacy rates that could hasten the end to the COVID-19 pandemic. Meanwhile, federal and state health authorities have been racing against the clock to develop vaccine distribution guidelines as the country awaits approval from the U.S. Food and Drug Administration of the first vaccine candidates.
To help you make sense of what state and federal plans mean for I/DD service providers and the people they support, ANCOR has partnered with the American Academy of Developmental Medicine & Dentistry to present COVID-19 Vaccine Prioritization: What’s Next? Join this session to hear the latest on the federal guidelines, understand what is currently in states’ allocation plans, and identify what you need to consider regarding vaccine prioritization and distribution.
Matt Holder, MD, Past President, AADMD
Shannon McCracken, Vice President of Government Relations, ANCOR
Donna Martin, Director of State Partnerships & Special Projects, ANCOR
This free webinar will be recorded and the recording will be made available after the session, although participating in the live broadcast means you’ll have the opportunity to ask questions of the presenters.